A framework for incorporating cost-effectiveness in evidence-based clinical practice guidelines
- 12 April 1999
- journal article
- Published by Elsevier in Health Policy
- Vol. 47 (1) , 37-52
- https://doi.org/10.1016/s0168-8510(99)00007-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary careBMJ, 1998
- Economic evaluation under managed competition: Evidence from the U.K.Social Science & Medicine, 1997
- North of England evidence based guidelines development project: methods of guideline developmentBMJ, 1996
- What is the ideal study design for evaluation of treatment for heart failure?: Insights from trials assessing the effect of ACE inhibitors on exercise capacityEuropean Heart Journal, 1996
- The use of economic evaluation in health care: Australian decision makers' perceptionsHealth Policy, 1995
- Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunctionJournal of the American College of Cardiology, 1994
- Setting priorities in the new NHS: can purchasers use cost-utility information?Health Policy, 1993
- Economic Analysis in Randomized Control TrialsMedical Care, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Essentials of health economics: part I (continued)-what is economics?BMJ, 1982